HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Extracellular matrix composition in COPD.

Abstract
Extracellular matrix (ECM) composition has an important role in determining airway structure. We postulated that ECM lung composition of chronic obstructive pulmonary disease (COPD) patients differs from that observed in smoking and nonsmoking subjects without airflow obstruction. We determined the fractional areas of elastic fibres, type-I, -III and -IV collagen, versican, decorin, biglycan, lumican, fibronectin and tenascin in different compartments of the large and small airways and lung parenchyma in 26 COPD patients, 26 smokers without COPD and 16 nonsmoking control subjects. The fractional area of elastic fibres was higher in non-obstructed smokers than in COPD and nonsmoking controls, in all lung compartments. Type-I collagen fractional area was lower in the large and small airways of COPD patients and in the small airways of non-obstructed smokers than in nonsmokers. Compared with nonsmokers, COPD patients had lower versican fractional area in the parenchyma, higher fibronectin fractional area in small airways and higher tenascin fractional area in large and small airways compartments. In COPD patients, significant correlations were found between elastic fibres and fibronectin and lung function parameters. Alterations of the major ECM components are widespread in all lung compartments of patients with COPD and may contribute to persistent airflow obstruction.
AuthorsRaquel Annoni, Tatiana Lanças, Ryan Yukimatsu Tanigawa, Marcus de Medeiros Matsushita, Sandra de Morais Fernezlian, Andreina Bruno, Luiz Fernando Ferraz da Silva, Peter J Roughley, Salvatore Battaglia, Marisa Dolhnikoff, Pieter S Hiemstra, Peter J Sterk, Klaus F Rabe, Thais Mauad
JournalThe European respiratory journal (Eur Respir J) Vol. 40 Issue 6 Pg. 1362-73 (Dec 2012) ISSN: 1399-3003 [Electronic] England
PMID22496324 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biglycan
  • Chondroitin Sulfate Proteoglycans
  • Decorin
  • Fibronectins
  • LUM protein, human
  • Lumican
  • Tenascin
  • Collagen
  • Keratan Sulfate
Topics
  • Adult
  • Aged
  • Biglycan (metabolism)
  • Case-Control Studies
  • Chondroitin Sulfate Proteoglycans (metabolism)
  • Collagen (metabolism)
  • Decorin (metabolism)
  • Extracellular Matrix (metabolism)
  • Female
  • Fibronectins (metabolism)
  • Humans
  • Immunohistochemistry (methods)
  • Keratan Sulfate (metabolism)
  • Lumican
  • Lung (metabolism, surgery)
  • Male
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive (metabolism)
  • Respiratory Function Tests
  • Smoking (adverse effects)
  • Tenascin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: